What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Biochemistry
The scientist’s investigation covers issues in Ischemia, Anesthesia, Pharmacology, Ischemic preconditioning and Cardioprotection.
His Ischemia study incorporates themes from Potassium channel, Arachidonic acid, -Naloxone, Myocyte and Receptor antagonist.
The various areas that Garrett J. Gross examines in his Anesthesia study include Occlusion, Glibenclamide and Adenosine.
His Pharmacology research integrates issues from Myocardial stunning and Agonist, Opioid receptor, Antagonist, Opioid.
His Ischemic preconditioning research is multidisciplinary, relying on both Receptor and Potassium channel blocker.
Cardioprotection is a subfield of Internal medicine that he studies.
His most cited work include:
- Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. (877 citations)
- Sarcolemmal Versus Mitochondrial ATP-Sensitive K+ Channels and Myocardial Preconditioning (470 citations)
- Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. (388 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Anesthesia, Internal medicine, Pharmacology, Ischemia and Cardioprotection.
His work in Anesthesia tackles topics such as Coronary occlusion which are related to areas like Radioactive microsphere technique.
His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Cardiology.
His research in Pharmacology intersects with topics in Adenosine and Opioid receptor, Receptor, Antagonist, Opioid.
His research in Ischemia tackles topics such as Potassium channel which are related to areas like Myocardial stunning.
His work carried out in the field of Cardioprotection brings together such families of science as Nitric oxide synthase, Agonist, Biochemistry, Wortmannin and Katp channels.
He most often published in these fields:
- Anesthesia (43.14%)
- Internal medicine (43.14%)
- Pharmacology (40.29%)
What were the highlights of his more recent work (between 2006-2019)?
- Pharmacology (40.29%)
- Cardioprotection (31.71%)
- Ischemia (35.43%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pharmacology, Cardioprotection, Ischemia, Anesthesia and Internal medicine.
His research integrates issues of Receptor, Biochemistry, Opioid, Arachidonic acid and Reperfusion injury in his study of Pharmacology.
He has researched Cardioprotection in several fields, including Myocardial stunning, Nitric oxide synthase, Antagonist and Wortmannin.
Garrett J. Gross is interested in Ischemic preconditioning, which is a branch of Ischemia.
His Anesthesia research incorporates elements of Capsaicin, Reperfusion therapy, Calcineurin and TRPV1, Transient receptor potential channel.
His Internal medicine research incorporates themes from Endocrinology, Antibiotics and Cardiology.
Between 2006 and 2019, his most popular works were:
- Intestinal microbiota determine severity of myocardial infarction in rats (158 citations)
- Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia (130 citations)
- Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. (120 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Biochemistry
Garrett J. Gross mainly focuses on Cardioprotection, Internal medicine, Pharmacology, Ischemia and Reperfusion injury.
His Cardioprotection study combines topics in areas such as Adenosine A1 receptor, Morphine, Antagonist and Wortmannin.
Garrett J. Gross interconnects Tyrosine, Endocrinology, Antibiotics and Cardiology in the investigation of issues within Internal medicine.
His Pharmacology study integrates concerns from other disciplines, such as Anesthesia, Arachidonic acid and Biochemistry.
His Ischemia research focuses on Ischemic preconditioning in particular.
His biological study deals with issues like Receptor, which deal with fields such as Slit and Hemodynamics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
